ChemicalBook > CAS DataBase List > Lurbinectedin

Lurbinectedin

Product Name
Lurbinectedin
CAS No.
497871-47-3
Chemical Name
Lurbinectedin
Synonyms
PM01183;PM 01183;PM-01183;Rubitidine;LURBINECTEDIN;Lurbinectidine;UNII-2CN60TN6ZS;D3-Lurbinectedin;Lubic alternative;Rupee substitution
CBNumber
CB82628057
Molecular Formula
C41H44N4O10S
Formula Weight
784.88
MOL File
497871-47-3.mol
More
Less

Lurbinectedin Property

Density 
1.55±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
Solid
pka
9.79±0.40(Predicted)
color 
White to light yellow
InChIKey
YDDMIZRDDREKEP-JUVYNUGVNA-N
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H400Very toxic to aquatic life

H410Very toxic to aquatic life with long lasting effects

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P273Avoid release to the environment.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P330Rinse mouth.

P391Collect spillage. Hazardous to the aquatic environment

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Biorbyt Ltd
Product number
orb573146
Product name
Lurbinectedin
Purity
>98%
Packaging
5mg
Price
$2839
Updated
2021/12/16
ChemScene
Product number
CS-6323
Product name
Lurbinectedin
Purity
99.91%
Packaging
2mg
Price
$3360
Updated
2021/12/16
Biorbyt Ltd
Product number
orb573146
Product name
Lurbinectedin
Purity
>98%
Packaging
10mg
Price
$4173.5
Updated
2021/12/16
Biorbyt Ltd
Product number
orb573146
Product name
Lurbinectedin
Purity
>98%
Packaging
25mg
Price
$5210.5
Updated
2021/12/16
ChemScene
Product number
CS-6323
Product name
Lurbinectedin
Purity
99.91%
Packaging
100ug
Price
$550
Updated
2021/12/16
More
Less

Lurbinectedin Chemical Properties,Usage,Production

Description

Lurbinectedin is a synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. Lurbinectedin covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death. Lurbinectedin was approved for medical use in the United States in June 2020.

Uses

Lurbinectedin is being developed for the treatment of various cancers. It has been granted approval for treatment of metastatic small cell lung cancer.

Application

Lurbinectedin is indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

Biological Activity

Lurbinectedin (PM01183, PM-1183, LY-01017, Tryptamicidin, Zepsyre, ZEPZELCA), a DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity. Lurbinectedin inhibits RMG1 and RMG2 cell growth with IC50 of 1.25 nM and 1.16 nM, respectively.

Mechanism of action

Lurbinectedin is a next-generation DNA minor groove binder that exerts potent antitumor activity in a low nanomolar range. Furthermore, it inhibits RNA-polymerase-II activity and promotes its specific degradation by the ubiquitin/proteasome machinery. In several human cancer cell lines, lurbinectedin blocks the transcription process through binding to CG-rich sequences near the promoters of protein-coding genes. This drug triggers both the degradation of phosphorylated RNA polymerase II (Pol II) on the DNA template and the generation of SSBs and DSBs that drive tumor cells to apoptosis. By attenuating the activity of the nucleotide excision repair (NER) mechanism, lurbinectedin was able to overcome cisplatin resistance in NER hyperactive cell lines. Lurbinectedin was also shown to inactivate Ewing Sarcoma Oncoprotein (EWS-FLI1) by nuclear redistribution leading to promotor inactivity and decreased mRNA and protein levels[1-2].

Side effects

The most common side effects include leukopenia, lymphopenia, fatigue, anemia, neutropenia, increased creatinine, increased alanine aminotransferase, increased glucose, thrombocytopenia, nausea, decreased appetite, musculoskeletal pain, decreased albumin, constipation, dyspnea, decreased sodium, increased aspartate aminotransferase, vomiting, cough, decreased magnesium and diarrhea.

Synthesis

Phenol 268 was subjected to oxidative dearomatization using phenylselenic anhydride. Subsequent esterification of the primary alcohol with (R)-N-Alloc-S-Fm-Cys (269) gave the hydroxy enone 270 in 72% overall yield for this two-step reaction. Macrocyclization followed the one-pot protocol reported by Corey to afford the sulfide 271 in 51% yield. Reduction to remove all allyl and Alloc protecting groups afforded the amine 272 in 85% yield. Amine 272 was reacted with 4-carboxaldehyde-1-methylpyridinium salt (273) to afford the oxalate 274 in 52% yield. Pictet-Spengler reaction with the tryptophan derivative 275 followed by iminium ion-mediated quenching of the cyano group by injection and hydrolysis afforded rubicin in 77% overall yield.

in vitro

Lurbinectedin exhibits significant antitumor activity toward chemosensitive and chemoresistant CCC cells in vitro. Lurbinectedin plus SN-38 combination has strong synergistic effects on both the cisplatin-resistant and paclitaxel-resistant CCC cell lines.

in vivo

An examination of mouse CCC cell xenografts reveals that lurbinectedin significantly inhibits tumor growth. Lurbinectedin plus SN-38 combination results in a significant synergistic effect. Everolimus significantly enhances the antitumor activity of lurbinectedin-based chemotherapies.

Mode of action

Lurbinectedin is an Alkylating Drug. The mechanism of action of lurbinectedin is as an Alkylating Activity.

References

[1] Kauffmann-Guerrero D, et al. Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin. Lung Cancer: Targets and Therapy, 2020; 11: 27–31.
[2] Gadducci A, et al. Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma. Frontiers in Oncology, 2022; 12: 914342.

Lurbinectedin Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lurbinectedin Suppliers

WuYan Pharmaceutical Technology (Shanghai) Co., Ltd.
Tel
18621565901
Fax
021-61114075
Email
sales@wuyanpharm.com
Country
China
ProdList
117
Advantage
55
CE Pharm Co.,Ltd
Tel
15317222985
Fax
binbin.lin@cepharm.cn
Email
bingna.wang@cepharm.cn
Country
China
ProdList
154
Advantage
58
BrightGene Bio-medical Technology Co., Ltd.
Tel
0512-0512-62551764 18013103761
Fax
0512-62551799
Email
sales01@bright-gene.com
Country
China
ProdList
61
Advantage
70
Shanghai WELI Biotechnology Co.,Ltd
Tel
18621923808
Fax
0530-5859609
Email
ytt@welidream.com
Country
China
ProdList
37
Advantage
58
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6003
Advantage
61
Wuhan Sunrise Technology Development Co., Ltd.
Tel
27-027-83314682 13554138826
Fax
+86 (27) 8331-4682
Email
whsrtech@vip.163.com
Country
China
ProdList
246
Advantage
62
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
UHN Shanghai Research & Development Co., Ltd.
Tel
021-58958002 18930822973
Fax
+86 (21) 5895-8628
Email
sales@uhnshanghai.com
Country
China
ProdList
998
Advantage
58
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
Shanghai Biolang biotechnology Co.,Ltd
Tel
17764003753
Fax
13669031409
Email
2326587775@qq.com
Country
China
ProdList
188
Advantage
55
Shanghai Biolang biotechnology Co.,Ltd
Tel
17764003753
Fax
13669031409
Email
2326587775@qq.com
Country
China
ProdList
188
Advantage
55
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Country
China
ProdList
6468
Advantage
55
SPIRO PHARMA
Tel
Fax
-
Email
eric_feng1954@126.com
Country
China
ProdList
9248
Advantage
55
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Fax
QQ:3008007432
Email
3008007409@qq.com
Country
China
ProdList
71826
Advantage
60
ShangHai Biochempartner Co.,Ltd
Tel
177-54423994 17754423994
Fax
QQ:2853530913
Email
2853530910@QQ.com
Country
China
ProdList
8000
Advantage
62
ShangHai ShuaiDian MEDICAL TECHNOLOGY CO.,LTD.
Tel
15821556986
Email
shshuaidian@126.com
Country
China
ProdList
139
Advantage
58
Hubei widely chemical technology Co., Ltd.
Tel
027-59402396 13419635609
Fax
027-83989310
Email
13419635609@163.com
Country
China
ProdList
1991
Advantage
55
Wellman Pharmaceutical Group Limited
Tel
027-027-83778875 15807197853
Fax
027-83991220
Email
15807197853@163.com
Country
China
ProdList
3932
Advantage
58
Chemleader Biomedical Co., Limited.
Tel
021-58180488
Fax
021-58180499
Email
sales@MedChemLeader.com
Country
China
ProdList
1006
Advantage
58
Beijing Mesochem Technology Co., Ltd.
Tel
010-57862036 18811083386
Email
msales@mesochem.com
Country
China
ProdList
210
Advantage
58
Shanghai Zhibang Biological Medicine Co., LTD
Tel
021-54285032 18116461626
Fax
021-54285032
Email
25493162@qq.com
Country
China
ProdList
148
Advantage
58
Madision Biomedical Co., Ltd.
Tel
028-87439248 19150327610
Fax
028-87439248
Email
553691721@qq.com
Country
China
ProdList
64
Advantage
58
Zhengzhou Acme Chemical Co., Ltd.
Tel
0371-037163312495,13303845143 13303845143
Fax
QQ3001379618
Email
3001379618@qq.com
Country
China
ProdList
10267
Advantage
58
Abydos Scientific
Tel
025-84767922 18936879710
Email
sales@abydoscientific.com
Country
China
ProdList
1002
Advantage
58
Changzhou Yongfeng Biomedicine Co. Ltd.
Tel
15006117673
Fax
2973592490@.com
Email
2973592490@qq.com
Country
China
ProdList
299
Advantage
58
Taizhou Crene Biotechnology Co. Ltd.
Tel
+86-0576-88813233 +86-13396860566
Email
sales@pharm-intermediates.com
Country
China
ProdList
1991
Advantage
58
Zhengzhou Alfa Chemical Co.,Ltd
Tel
+8618530059196
Email
sale04@alfachem.cn
Country
China
ProdList
11784
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10473
Advantage
58
Hebei Yanxi Chemical Co., Ltd.
Tel
+8618531123677
Email
faithe@yan-xi.com
Country
China
ProdList
5853
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30229
Advantage
58
Shanghai Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
021-58955996
Email
info@chemexpress.com
Country
China
ProdList
821
Advantage
58
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Tel
18818260767
Fax
QQ 3610331285
Email
sales@chemegen.com
Country
China
ProdList
11218
Advantage
58
CE Pharm Co.,Ltd
Tel
+86 13816833708
Email
binbin.lin@cepharm.cn
Country
CHINA
ProdList
52
Advantage
58
wuhan dingxingtong Chemical Technology Co., Ltd Co., Ltd
Tel
027-59207796 13429867250
Fax
027-59207796
Email
w13429867250@163.com
Country
China
ProdList
1995
Advantage
58
Shanghai Zeye Biotechnology Co., Ltd.
Tel
021-021-61998551 13122364865
Email
sale1@shzysw.net
Country
China
ProdList
9778
Advantage
58
Shanghai Botuo Biotechnology Co., LTD
Tel
16621358918
Fax
QQ:402135374
Email
botuopharma888@163.com
Country
China
ProdList
9208
Advantage
58
Wuhan Dingxintong Pharmaceutical Co. , Ltd.
Tel
027-83984790 17720532645
Fax
027-83984790
Email
t17720532645@163.com
Country
China
ProdList
1000
Advantage
58
Wuhan Dingxintong Pharmaceutical Co. , Ltd.
Tel
15871722230
Fax
2796190295
Email
15871722230@163.com
Country
China
ProdList
4686
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15727060112
Email
yutianchun2007@126.com
Country
China
ProdList
9814
Advantage
58
Shanghai Minkai Biological Technology Co., Ltd
Tel
021-021-52919136 17315815539
Email
2804155403@qq.com
Country
China
ProdList
180
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
400-880-2824 18107960669
Fax
18140514863
Email
79046690@qq.com
Country
China
ProdList
1242
Advantage
58
Sichuan Qingmu Pharmaceutical Co., Ltd.
Tel
028-87827187 18681376319
Email
sales@eastonpharma.cn
Country
China
ProdList
66
Advantage
60
Hubei Yuanmeng Biotechnology Co., Ltd
Tel
027-68897569 18120462897
Fax
027-68897569
Email
fiona@yuanmengbio.com
Country
China
ProdList
4657
Advantage
58
Zhengzhou convergence chemical co., LTD
Tel
0371-0371-55153829 18003835034
Email
2853979819@qq.com
Country
China
ProdList
9998
Advantage
58
Shenzhen Shengda Pharmaceutical co Limited
Tel
0755-85269922 13424394241
Fax
QQ:1799060443
Email
sales@shengdapharm.com
Country
China
ProdList
505
Advantage
58
Nantong Hi-Future Biotechnology Co., Ltd
Tel
18051384581
Email
sales@chemhifuture.com
Country
China
ProdList
2998
Advantage
58
SINO High Goal Chemical Technology Co., Ltd.
Tel
021-57646680 18306277365
Email
guoxin@chembiobanksh.com
Country
China
ProdList
2666
Advantage
58
JinOu Biomedical (Nanjing) Co., Ltd.
Tel
13000000000
Fax
jinoupharma@163
Email
jinoupharma@163.com
Country
China
ProdList
11721
Advantage
58
Hubei Kele Fine Chemical Co., Ltd
Tel
027-59101668 19945030958
Fax
027-59101668
Email
2881924765@qq.com
Country
China
ProdList
7937
Advantage
58
More
Less

View Lastest Price from Lurbinectedin manufacturers

Hebei Yanxi Chemical Co., Ltd.
Product
Lurbinectedin 497871-47-3
Price
US $30.00-1.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
10 tons
Release date
2023-11-24
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Lurbinectedin 497871-47-3
Price
US $0.00/g
Min. Order
1g
Purity
More Than 99%
Supply Ability
100kg/Month
Release date
2024-10-14
Henan Fengda Chemical Co., Ltd
Product
Lurbinectedin 497871-47-3
Price
US $6.00-1.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
g-kg-tons, free sample is available
Release date
2024-03-28

497871-47-3, LurbinectedinRelated Search:


  • Lurbinectedin (PM01183)
  • LURBINECTEDIN
  • PM 01183
  • PM01183
  • PM-01183
  • PM01183;PM-01183;PM 01183
  • Lurbinectidine
  • Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-[1H]pyrido[3,4-b]indol]-19-one, 5-(acetyloxy)-2',3',4',6,6a,7,9',13,14,16-decahydro-8,14-dihydroxy-6',9-dimethoxy-4,10,23-trimethyl-, (1'R,6R,6aR,7R,13S,14S,16R)- (9CI)
  • UNII-2CN60TN6ZS
  • Lurbinectedin,DNA/RNA Synthesis,inhibit,DNA Alkylator/Crosslinker,PM-01183,Inhibitor,PM 01183
  • Rubitidine
  • Cypermethrin Impurity 18 (Phenothrin)
  • Lurbinectedin Impurity
  • Lubic alternative
  • Rupee substitution
  • D3-Lurbinectedin
  • 497871-47-3
  • C41H44N4O10S